Development of Novel Anticancer Drug-Carriers Targetable to Tumor Blood Vessels.
Development of Novel Anticancer Drug-Carriers Targetable to Tumor Blood Vessels.
批准号:
04557072
负责人:
KATO Tetsuro
金额:
$9.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994
中文摘要
提高抗癌药物在肿瘤血管床中的再分布和控制药物的释放是最有效的途径。这可以通过使用药物载体复合物来实现。尽管已经提出了多种载体,但是它们中没有一种在载药率、粒度、药物释放速率和/或储存稳定性方面满足实际应用。本研究正是针对这些问题而设计的。该载体的优点是:1)基于凝聚原理的制备工艺简单,2)水溶性药物的广泛利用性,3)高载药率高达80%,4)药物释放速率可控,5)室温储存稳定性。然而,不可避免的缺点是难以产生小于100 μ m的粒度。为了克服这个问题,我们开发了一种新的方法来获得大量的小微胶囊(<100 μ m)。 ...更多信息 有了这种新产品,小肿瘤供血动脉成为微囊化疗栓塞的靶点。以DL-乳酸/羟基乙酸共聚物为原料,采用水相干乳法制备了微球。该微球有效地结合油溶性药物。抗血管生成药物TNP-470(烟曲霉素的衍生物)制成聚乳酸微球,对兔VX2肿瘤有抗肿瘤作用。TNP-470溶于甘油三酸酯溶液(MIGLYOL)中,与传统的油性载体如芝麻油和碘油相比,由于药物释放时间延长和稳定性好,具有更强的抗肿瘤作用。MIGLYOL是一种新型的油性药物载体。diAc-Hp在肿瘤组织中积累并对超声有反应。在超声辐照下,双乙酸-Hp-丝裂霉素C偶联物增强了母体药物的细胞毒作用,表明双乙酸-Hp作为药物载体的可行性。少
英文摘要
The most effective approach to enhance the anticancer drugs is the restrive distribution in the tumor vascular beds and the controlled release of the available drugs. This can be achieved by using drug-carrier complexes. Though a variety carriers have been proposed, none of them saticefy the practical use in respect to drug loading rate, particle size, drug release rate and/or stability in storage. This research was designed to improve these problems of drug carriers.Ethylcellulose microcapsule. The advantage of this carrier is ; 1) simple processes for preparation based on the principle of coacervation, 2) wide availability for water-soluble drugs, 3) high drug loading rate upto 80%, 4) controlability of drug release rate, and 5) stability in storage at room temparature. While, the inevitable disadvantage is the difficulty to produce a particle size of smaller than 100 um. To overcome this problem, we developed a new method to obtain a large quantity of small microcapsules (<100um) . … More With this new product, small tumorfeeding arteries become the target of microcapsule chemoembolization.Polylactic microsphere. Preparation of microspheres with copoly (DL-lactic /glycolic acid was developed using an in-water drying emulsion method. This microsphere effectively conjugate oil-soluble drugs. An antiangiogenetic drug, TNP-470 (a derivative of fumagillin) , proved to be prepared as polylactic microspheres and exert an antitumor effect on VX2 tumors in rabbits.Triqlyceride (oily carrier) . TNP-470 dissolved in triglyceride solution (MIGLYOL) exerted an enchanced antitumor effect due to the prolonged drug-release as well as the stability as compared with the conventional oily carriers such as sexame oil and lipiodol. MIGLYOL may be used a novel oily drug-carrier.Diacetylhematoporphyrin (diAc-Hp) . diAc-Hp accumulates in tumor tissues and responds to ultrasound. The diAc-Hp-mitomycin C conjugate enhanced the cytotoxic effect of the parent drugs under ultrasonic irradiation, indicating the aplicability of diAc-Hp as a drug-carrier. Less
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kakinuma H,Sato K,Miura K,Sasaki S,Kato T :"Effect of mictomycin C microcapsule chemoembolization on bone metastases of prostatic and renal cancer." Japanese Journal of Urology. 56. 1116-1123 (1994)
Kakinuma H、Sato K、Miura K、Sasaki S、Kato T:“密霉素 C 微胶囊化疗栓塞对前列腺癌和肾癌骨转移的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kato,T.: "Microspheres and Regional Cancer Therapy(ed.N.Willmott)" CRC Press,Boca Raton,FL,USA, 2 (1994)
Kato,T.:“微球和局部癌症治疗(N.Willmott 编)”CRC Press,美国佛罗里达州博卡拉顿,2 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okada H, Yamamoto M, Heya T, et al: "Drug delivery using biodegradable microspheres." Journal of Controlled Release. 28. 221-229 (1994)
Okada H、Yamamoto M、Heya T 等人:“使用可生物降解微球进行药物输送。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okada H,Doken Y,Ogawa Y,Toguchi H :"Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers." Pharmaceutical Research, 11 : 1199-1203,1994.
Okada H、Doken Y、Okawa Y、Toguchi H:“使用生物可降解聚合物制备醋酸亮丙瑞林三个月可注射微球。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okada,H.et al.: "Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers." Pharmaceutical Research. 11. 1143-1147 (1994)
Okada,H.et al.:“使用生物可降解聚合物制备三个月可注射的醋酸亮丙瑞林微球。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 31 条
War of Information on the Siberian internment returnees between USA and USSR
-
批准号:26380188
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2014
-
负责人:KATO Tetsuro
-
依托单位:
The War of Information about a member of the wartime Japanese Embassy in Germany: Shigeki Sakimura and his Desertion
-
批准号:23530170
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:KATO Tetsuro
-
依托单位:
Politics of Mobility and Information Network : The "Empire" and the Crossing Border by "Multitude"
-
批准号:19330031
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2007
-
负责人:KATO Tetsuro
-
依托单位:
Informational Community of Japanese Intellectuals Abroad during Two World Wars
-
批准号:15530087
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:KATO Tetsuro
-
依托单位:
RESEARCH BY INTERNET ON THE JAPANESE ANTI-NAZIS INTELLECTUALS IN BERLIN : FROM WEIMAR GERMAN TO POST-WAR JAPANESE DEMOCRACY
-
批准号:10620063
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:KATO Tetsuro
-
依托单位:
Dynamics and Biological Significance of Vascular Growth Factors in Urogenital Cancers.
-
批准号:10470330
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.32万
-
财政年份:1998
-
负责人:KATO Tetsuro
-
依托单位:
Development of Antibodies to Angiogenic Factors for Diagnosis and Therapy of Solid Tumors.
-
批准号:09557129
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:1997
-
负责人:KATO Tetsuro
-
依托单位:
Pathological and biological analyzes of angiogenesis on urological cancers
-
批准号:08457419
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$1.09万
-
财政年份:1996
-
负责人:KATO Tetsuro
-
依托单位:
The Scale and Mechanism of Japanese Victims of Stalinist Terror in the USSR in the 1930s
-
批准号:07620055
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:KATO Tetsuro
-
依托单位:
Significance of c-erbB-2 and its ligand affecting malignant potential of urological carcinomas.
-
批准号:05454430
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1993
-
负责人:KATO Tetsuro
-
依托单位:
Analysis of Histopathological Heterogeneity of Urinary Bladder Cancer by Molecular Biological Technique.
-
批准号:63480357
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1988
-
负责人:KATO Tetsuro
-
依托单位:
Nuclear Magnetic Resonance Analysis in Urological Disorders.
-
批准号:59480324
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1984
-
负责人:KATO Tetsuro
-
依托单位:
Synthesis of New Hematoporphyrin Derivatives Providing a Tumor-Specificity
-
批准号:59870053
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$4.29万
-
财政年份:1984
-
负责人:KATO Tetsuro
-
依托单位:
国内基金
海外基金
基于"Carrier-free"概念构建的高载药量的主动靶向双药纳米纤维递药体系的疗效评价及机制研究
-
批准号:81472781
-
项目类别:面上项目
-
资助金额:74.0万元
-
批准年份:2014
-
负责人:李晓林
-
依托单位: